Half-year report · Q2
9265.TEDINET S100V29Y
Period2024-06-01 → 2024-11-30
Filed2025-01-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥31.4bn | 2024-06-01 → 2024-11-30 | Cons. | Net sales |
| Revenue | ¥61.6bn | 2023-06-01 → 2024-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥28.9bn | 2023-06-01 → 2023-11-30 | Cons. | Net sales |
| Operating income | ¥522m | 2024-06-01 → 2024-11-30 | Cons. | Operating income |
| Operating income | ¥618m | 2023-06-01 → 2023-11-30 | Cons. | Operating income |
| Ordinary income | ¥552m | 2024-06-01 → 2024-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2023-06-01 → 2024-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥645m | 2023-06-01 → 2023-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥586m | 2024-06-01 → 2024-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥700m | 2023-06-01 → 2023-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥338m | 2024-06-01 → 2024-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥580m | 2023-06-01 → 2024-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥480m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥337m | 2024-06-01 → 2024-11-30 | Cons. | Profit loss |
| Net income | ¥477m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss |
| Total assets | ¥26.4bn | at 2024-11-30 | Cons. | Assets |
| Total assets | ¥26.6bn | at 2024-05-31 | Cons. | Assets |
| Total assets | ¥24.8bn | at 2023-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥17.7bn | at 2024-11-30 | Cons. | Liabilities |
| Total liabilities | ¥18.0bn | at 2024-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.7bn | at 2024-11-30 | Cons. | Net assets |
| Net assets / equity | ¥8.6bn | at 2024-05-31 | Cons. | Net assets |
| Net assets / equity | ¥8.3bn | at 2023-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.4bn | at 2024-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.3bn | at 2024-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥4.4bn | at 2024-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.3bn | at 2024-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.0bn | at 2023-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.8bn | at 2023-05-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥633m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥878m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥544m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥19m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥154m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥239m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥335m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥123m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥136.8 | 2024-06-01 → 2024-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥227.96 | 2023-06-01 → 2024-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥188.05 | 2023-06-01 → 2023-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 32.9% | at 2024-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.2% | at 2024-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.5% | at 2023-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-06-01 → 2024-11-30 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-06-01 → 2024-11-30 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2024-06-01 → 2024-11-30 | −¥519m |
| jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥113m |
| jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥112m |
| jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2024-06-01 → 2024-11-30 | ¥0 |
| jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2024-06-01 → 2024-11-30 | −¥82m |
| jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥31.2bn |
| jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥31.2bn |
| jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segment | revenue intersegment | 2024-06-01 → 2024-11-30 | ¥0 |
| jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥1.1bn |
| jpcrp040300-q2r_E33393-000Medical Mallreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥35m |
| jpcrp040300-q2r_E33393-000Medical Mallreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥35m |
| jpcrp040300-q2r_E33393-000Medical Mallreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥0 |
| —segment total | revenue | 2024-06-01 → 2024-11-30 | ¥31.4bn |
| —segment total | revenue external | 2024-06-01 → 2024-11-30 | ¥31.4bn |
| —segment total | revenue intersegment | 2024-06-01 → 2024-11-30 | ¥0 |
| —segment total | segment profit | 2024-06-01 → 2024-11-30 | ¥1.0bn |
| Reconciling Itemsreconciling | revenue | 2023-06-01 → 2023-11-30 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2023-06-01 → 2023-11-30 | −¥494m |
| jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥146m |
| jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥146m |
| jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥0 |
| jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥6m |
| jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥28.7bn |
| jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥28.7bn |
| jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segment | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥0 |
| jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥1.1bn |
| jpcrp040300-q2r_E33393-000Medical Mallreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥36m |
| jpcrp040300-q2r_E33393-000Medical Mallreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥36m |
| jpcrp040300-q2r_E33393-000Medical Mallreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥2m |
| —segment total | revenue | 2023-06-01 → 2023-11-30 | ¥28.9bn |
| —segment total | revenue external | 2023-06-01 → 2023-11-30 | ¥28.9bn |
| —segment total | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥0 |
| —segment total | segment profit | 2023-06-01 → 2023-11-30 | ¥1.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 485
| Item | Context | Value | Unit |
|---|---|---|---|
| Non operating income | Prior1YTDDuration | 40000000 | JPY |
| Non operating income | CurrentYTDDuration | 40000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 0 | JPY |
| Interest expenses noe | CurrentYTDDuration | 1000000 | JPY |
| Foreign exchange losses noe | Prior1YTDDuration | 4000000 | JPY |
| Foreign exchange losses noe | CurrentYTDDuration | － | JPY |
| Loss on sales of notes payable noe | Prior1YTDDuration | 3000000 | JPY |
| Loss on sales of notes payable noe | CurrentYTDDuration | 4000000 | JPY |
| Equity in losses of affiliates noe | Prior1YTDDuration | 0 | JPY |
| Equity in losses of affiliates noe | CurrentYTDDuration | 1000000 | JPY |
| Other noe | Prior1YTDDuration | 4000000 | JPY |
| Other noe | CurrentYTDDuration | 2000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 14000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 9000000 | JPY |
| Ordinary income | Prior1YTDDuration | 645000000 | JPY |
| Ordinary income | CurrentYTDDuration | 552000000 | JPY |
| Reversal of allowance for doubtful accounts ei | Prior1YTDDuration | 54000000 | JPY |
| Reversal of allowance for doubtful accounts ei | CurrentYTDDuration | 36000000 | JPY |
| Extraordinary income | Prior1YTDDuration | 54000000 | JPY |
| Extraordinary income | CurrentYTDDuration | 36000000 | JPY |
| Loss on step acquisitions el | Prior1YTDDuration | － | JPY |
| Loss on step acquisitions el | CurrentYTDDuration | 3000000 | JPY |
| Extraordinary loss | Prior1YTDDuration | － | JPY |
| Extraordinary loss | CurrentYTDDuration | 3000000 | JPY |
| Income before income taxes | Prior1YTDDuration | 700000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 586000000 | JPY |
| Income taxes current | Prior1YTDDuration | 48000000 | JPY |
| Income taxes current | CurrentYTDDuration | 70000000 | JPY |
| Income taxes deferred | Prior1YTDDuration | 175000000 | JPY |
| Income taxes deferred | CurrentYTDDuration | 178000000 | JPY |
| Income taxes | Prior1YTDDuration | 223000000 | JPY |
| Income taxes | CurrentYTDDuration | 249000000 | JPY |
| Profit loss | Prior1YTDDuration | 477000000 | JPY |
| Profit loss | CurrentYTDDuration | 337000000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | -2000000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | -1000000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 480000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 338000000 | JPY |
| Profit loss | Prior1YTDDuration | 477000000 | JPY |
| Profit loss | CurrentYTDDuration | 337000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | 54000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 61000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | 7000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -6000000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 62000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 55000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 539000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 392000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 542000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 393000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |